1.
Remingto
n GA: The Science and practice of Pharmacy, 19th Ed., Easton, PA, Mack Publishing, Vol.II (20th Ed.) Hypertension. 1995: 1069-1070.
2.
Charle
s S. and Gregory L: Antihypertensive drugs. The pharmaceutical Journal. 1999; 263.
3.
Chobania
n AV, Bakris GL and Black HR: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure". Hypertension. 2003; 42 (6): 1206-52.
4.
Hypertension
" (in en) (html). PubMed
Health. (2011-10-06). Retrieved (2011-10¬10). "Normal blood pressure is when your blood pressure is lower than 120/80 mmHg most of the time."
5. Carretero OA and Oparil S: Essential hypertension. Part I: definition and etiology". Circulation. 2000; 101 (3): 329¬35.
6. Secondary hypertension, Mayo Foundation for Medical Education and Research (2008) [1], Retrieved May 10,
2010.
7. World Health Report 2002: Reducing risks, promoting healthy life. Geneva, Switzerland: World Health Organization, 2002. http://www.who.int/whr/2002 .
8. Stamler J, Stamler R, Neaton JD, Wentworth D, Daviglus ML and Garside D: Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-
Available Online At www.ijprbs.com
Research Article
Ogbonna John, IJPRBS, 2012; Volume 1(4): 148-158
aged men and women. JAMA. 1999; 282: 2012-2018.
9.
Whelto
n PK, He J, Appel LJ, Cutler JA, Havas S and Kotchen TA: Primary prevention of hypertension: Clinical and public health advisory from The National High Blood Pressure Education Program.
JAMA. 2002; 288: 1882-1888.
10.
Psat
y BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M and Alderman MH: Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA 2003; 289: 2534-2544.
11.
Davigno
n J and Ganz P: Role of endothelial dysfunction in atherosclerosis.
Circulation 2004; 109: III27-III32.
12.
Lav
i S, Yang EH, Prasad A, Mathew V, Barsness GW and Rihal CS: The interaction between coronary endothelial dysfunction, local oxidative stress, and endogenous nitric oxide in humans. Hypertension 2008; 51:
127-133.
13.
K-
Y Chen, S-W Rha, Y-J Li, KL Poddar, Z Jin, Y Minami, S Saito, JH Park, JO Na, CU
Choi, HE Lim, JW Kim, EJ Kim, CG Park, HS
Seo and DJ Oh: Impact of hypertension on
ISSN: 2277-8713 IJPRBS
coronary artery spasm as assessed with intracoronary acetylcholine provocation test. Journal of Human Hypertension 2010; 24:77-85.
14. Cappuccio FP, Micah FB, Emmett L, Kerry SM, Antwi S, Martin-Peprah R, Phillips RO, Plange-Rhule J and Eastwood JB: Prevalence, detection, management and control of hypertension in Ashanti, West Africa. Hypertension.2004; 43: 1017-1022.
15. Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Arch
intern Med. 2003; 148: 1206-1252.
16. Mabadege AF: WHO-ISH guidelines for the management of hypertension complications in Africa: The Nigerian experience. Clin. Exptl. Hypertension. 1999;
21:671-681.
17. Ravogli A, Trazzi S, Villani A, Mutti E, Guspidi C, Sampieri L, Ambroggi L, Parati G, Zanchetti A and Mancia G: Early 24-hour blood pressure elevation in normotensive subjects with parenteral hypertension. Hypertension. 1990; 16: 491-497.
Available Online At www.ijprbs.com
Research Article
Ogbonna John, IJPRBS, 2012; Volume 1(4): 148-158
18.
Aguw
a CN: Therapeutic basis of Clinical Pharmacy in the tropics.(2nd ed.). Optimal publishers, Enugu. 1996: 62-69.
19.
Ud
u E and Agu GA: New system economics. A senior secondary course. Africana-Feb, Publishers Ltd. 1999.
20. ILO.
Pres
s releases on cost of workplace stress are rising with depression increasing common. ILO, Geneva, October, 2000.
21. Ambrosioni E: Pharmaeconomics of hypertension management: The place of combination therapy. Pharmacoeconomics. 2001; 19: 337-347.
22.
Gle
n TS. Primer on pharmacoeconomics for the pharmacist. http://www///netCE.com.2005
23.
Europea
n Community Council Directive on the ethics of experiments involving laboratory animals (86/609/EEC), November 24, 1986.
24.
Klatsk
y AL: Alcohol and hypertension. Clinica Chimica Acta. 1996; 246:91-105.
25.
Thadhan
I R, Camargo CA Jnr and Stampfer MJ: Prospective study of moderate alcohol consumption and risk of
ISSN: 2277-8713 IJPRBS
hypertension in young women. Archives of Internal Medicine. 2002; 162: 569-574.
26. Niskanen L, Laaksonen DE and Nyyssonen K: Inflammation, abdominal obesity, and smoking as predictors of hypertension. Hypertension. 2004; 44: 859¬865.
27. Rimm EB, Williams P and Fosher K: Moderate alcohol intake and lower risk of coronary heart disease: Meta-analysis of effects on lipids and haemostatic factors. British Medical Journal. 1999; 319: 1523¬1528.
28. Davies MJ, Baer DJ and Judd JT: Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: A randomized controlled trial. Journal of the American Medical Association: JAMA. 2002; 287: 2559-2562.
29. Croft JB, Freedman DS and Cresanta JL: Adverse influences of alcohol, tobacco, and oral contraceptive use on cardiovascular risk factors during transition to adulthood. American Journal of Epidemiology. 1987;
126: 202-213.
Thank you for copying data from http://www.arastirmax.com
